Note: The contents of this blog are for informational purposes only and should not be construed as medical advice or substitute for professional care. For medical emergencies, dial 911!
GSK's Cervarix drug gets support from Europe
Posted Jul 19th 2007 8:39AM by Brian White
Filed under: Drug, Cervical Cancer
GlaxoSmithKline's Cervarix cervical cancer drug is closer to approval in Europe after an influential medical panel there Wednesday afternoon suggested the drug be approved.
GSK expects EU approval in the coming months, with a European Cervarix launch possibly in 2007 sometime. Cervarix assists in the prevention of pre-cancerous lesions in the cervix
caused by the human papillomavirus (HPV), which has been a center of contention as certain states in the U.S. have suggested mandatory vaccinations for teenage girls against the HPV.
Cervical cancer is the second-most common form of cancer in women after breast cancer worldwide. So far, Cervarix has not received approval by the FDA in the U.S.
Tags: Cervarix, GlaxoSmithKline
Please keep your comments relevant to this blog entry. Email addresses are never displayed, but they are required to confirm your comments.
When you enter your name and email address, you'll be sent a link to confirm your comment, and a password. To leave another comment, just use that password.
To create a live link, simply type the URL (including http://) or email address and we will make it a live link for you. You can put up to 3 URLs in your comments. Line breaks and paragraphs are automatically converted — no need to use <p> or <br> tags.
